Back to trial details

Intake questionnaire

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

Applying to UChicago Medicine Comprehensive Cancer Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Triple Negative Breast Cancer?
3. Are you able to travel to Chicago for study visits?